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Summary 
Changes in T cell receptor (TCR) V/3 repertoire and their correlation with virologic events were 
investigated in rhesus monkeys after acute infection with the simian immunodeficiency virus 
(SIV).  11 genetically defined rhesus monkeys were experimentally infected with SIVm~ or a 
chimeric simian-human immunodeficiency  virus (SHIV), and their peripheral blood lymphocytes 
(PBL) and lymph nodes were prospectively assessed for TCR V~ gene expression. PBL and lymph 
nodes of the acutely infected monkeys demonstrated an expansion of selected V~-expressing T 
lymphocyte subpopulations as early as 3 d after infection. These expanded V/~-expressing  lymphocyte 
subpopulations were comprised predominantly of CD8+  cells. Six of seven infected monkeys 
sharing a single electrophoreticaUy defined major histocompatibility  complex class I allele exhibited 
a similar expansion of VB14-expressing PBL. Sequence analyses of V-D-J segments of TCR-fl 
cDNA indicated that the VB-expressing  T  cell subpopulation expansion can be oligoclonal. 
SIVm,c-specific CDS+  cytotoxic T  lymphocytes were demonstrated in both PBL and lymph 
nodes of the infected monkeys at the time expansion of the selected V3-expressing cell subpopulations 
was seen. Finally, the expansion of the selected V3-expressing lymphocytes in PBL coincided 
with the emergence and clearance of SIV p27 from the plasma of the infected monkeys. These 
results demonstrate that acute infection of rhesus monkeys with SIVm~ or SHIV results in an 
expansion of CD8 + lymphocyte subpopulations expressing selected  V3 gene families. The selectively 
expanded T  lymphocytes may contribute to early viral clearance after  acute SIVmac or SHIV 
infection. 
T  lymphocytes play a major role in the antiviral immune 
response in primary HIV-1 infections. During the acute 
phase of an HIV-1 infection, individuals often transiently de- 
velop a high virus burden in the blood and lymphoid organs 
(1-5).  Virus-specific cytotoxic T lymphocytes (CTL) can be 
demonstrated in PBL and lymph nodes of AIDS virus-infected 
individuals as early as a few days after infection; and the evo- 
lution of this functional T  lymphocyte response correlates 
temporally with the initial clearance of the AIDS virus from 
these tissues (6-9). Furthermore, an expansion of selected TCR 
V~-expressing T lymphocyte subpopulations has been ob- 
served in PBL of individuals infected with HIV-1 or an acutely 
lethal variant of simian immunodeficiency virus (SIV) 1 (10, 
11). It will be important to elucidate further AIDS viruses- 
driven TCR Vfl-restricted T cell response and its importance 
in containing the spread of virus during the acute phase of 
infection. 
SIV-infected nonhuman primates have proven to be powerful 
models for the study of AIDS. SIVs are similar in sequence 
1 Abbreviations used in this paper: 1-D  IEF,  one-dimensional IEF;  1-D 
NEPHGE, one-dimensional nonequilibrium pH gradient electrophoresis; 
SHIV,  simian-human  immunodeficiency virus;  SIV, simian immuno- 
deficiency virus. 
21  J. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/95/07/0021/11  $2.00 
Volume  182  July 1995  21-31 to HIV (12), display a similar tropism for CD4-bearing lym- 
phocytes and macrophages (13), and cause an AIDS-like dis- 
ease in macaques (14). Early immunologic and virologic events 
can be studied prospectively in genetically defined macaques 
experimentally infected with SIV. The unique SIV/macaque 
model, therefore, provides an important system in which to 
explore  aspects  of T  lymphocyte interactions  with  AIDS 
viruses in vivo. In the present  study,  we have assessed the 
changes in TCR V~/repertoire after acute infection of rhesus 
monkeys with SIVmac or a chimeric simian-human immuno- 
deficiency virus (SHIV) as well as the temporal association 
of those changes with  virus  spread. 
Materials and Methods 
Viruses and Animals.  The viruses  used in this study included 
uncloned SIVmac strain 251 and two molecularly cloned viruses, 
SIVmac 239 and SHIV. This SHIV was comprised of SIVmac 239 
with the env, tat, rev, and vpu genes of the HIV-1 clone HXBc2 
(15). Three rhesus monkeys were experimentally infected by intra- 
venous inoculation with SIVm~ 251 (4 or 400 animal infectious 
doses per inoculation), four with SIVm~ 239 (104 TCID~0) and four 
with SHIV (4,000, 400, 40, and 4 median tissue culture infectious 
doses (TCIDs0), respectively). After virus inoculation, the animals 
were monitored for signs of disease. Infection of these animals was 
determined by monitoring their plasma for viral antigen using an 
antigen capture assay for SIV gag p27 protein (Coulter Corp., Hi- 
aleah,  FL) and their PBL for viral cDNA using the polymerase 
chain reaction (16). These monkeys were maintained in accordance 
with the guidelines of the Committee on Animals for the Harvard 
Medical School and the Guide  for the Care and Use of Laboratory 
Animals (Department of Health and Human Services Publication 
[National Institutes of Health] No.  82-23,  revised  1985). 
Characterization of  MHC Class land Class II Alleles.  The char- 
acterization of these monkeys' MHC class I and class II DR alleles 
was  carried out using one-dimensional isoelectric  focusing (1-D 
IEF) and one-dimensional nonequilibrium pH gradient electropho- 
resis (1-D NEPHGE), respectively (17, 18). Briefly, monkey B lym- 
phoblastoid cell lines were individually established by transforming 
PBL with Her~svirus t,  apio (19). Cells were 3ss trans-labeled for 6 h 
at 37~  Pelleted cells were lysed on ice in lysis buffer, and lysates 
were precleared by incubation with protein A-Sepharose CD4B beads 
(Sigma Chemical Co., St. Louis, MO) alone and beads  saturated 
with irrelevant antibodies.  Immunoprecipitation was performed by 
incubating the precleared lysates with protein A-Sepharose CL-4B 
beads saturated with the mAb BB7.7 (for class I) or the mAb L243 
(for class II DR). The beads were washed, and then treated with 
neuraminidase type VIII (Sigma Chemical Co.). BB7.7 immuno- 
precipitates were analyzed by 1-D IEF, whereas 1-D NEPHGE was 
used to analyze L243 immunoprecipitates as described previously 
(17, 18). 
Isolation and Fractionation of Lymphocyte Populations.  PBL were 
isolated from heparinized blood of the monkeys using FicoU/diatri- 
zoate gradient centrifugation. Peripheral lymph nodes were obtained 
by standard biopsy procedures before and after infection, and were 
carefully teased  to  generate  single  cell  suspensions.  CD4 +  or 
CD8 § lymphocytes were purified using anti-CD4  or anti-CD8 
antibody-conjugated Dynabeads (Dynal, Inc., Great Neck, NY). 
PBL were incubated with these immunomagnetic beads for 30 min 
at room temperature, and then selected in two cycles with a mag- 
netic particle concentrator. 
mRNA Extraction and cDNA Synthesis.  mRNA was extracted 
from  these  unfractionated  or  fractionated  lymphocytes  using 
guanidinium thiocyanate and oligo dT spun columns (mRNA ex- 
traction kit; Pharmacia Fine Chemicals, Piscataway, NJ). The first- 
strand cDNA was synthesized in a 20-/~1 final vol at 42~  for I h 
using 0.2-1 #g of mRNA,  1/~g of random hexanudeotides, and 
5 U of reverse transcriptase  (Promega Corp., Madison, WI). The 
samples were heated for 5 min at 95~  to terminate the reaction. 
PCR-based Analysis of TCR Vfl Gene Expression.  A semiquan- 
titative PCR-based method was used as previously described to de- 
termine the relative expression of the 24 V3 gene families in monkey 
lymphocytes (11, 16). The cDNA isolated from each lymphocyte 
sample was aliquoted into 25 tubes,  each containing a sense V3 
family-specific and an antisense C3 primer. As an internal control, 
each reaction tube also contained a pair of primers that amplified 
a 105-bp fragment of the constant region of macaque TCR-o~ chain. 
A 25-cycle PCR reaction was performed in a 30-/zl vol containing 
0.3 #M of each V3 and C3 primer, 0.03/~M of the 5' and 3' Cc~ 
primers, 1 U  of Taq polymerase (Perkin-Elmer Corp., Norwalk, 
CT), and 32p end-labeled  C~ and Cc~ primers (3  x  10  s cpm for 
each reaction). The cycle conditions were 1 min at 95~  55~ 
and 72~  respectively. The radiolabeled PCR products were elec- 
trophoresed through a 5% polyacrylamide gel, dried, and exposed 
to x-ray film. The separated V3-C3 and Cc~ bands were measured 
for their radioactivity using an Ambis 100 (Ambis Systems, Inc., 
San Diego, CA). The cpm of individual VB bands were normal- 
ized by dividing the cpm for each V3 band by the cpm of its as- 
sociated internal control Cc~ band.  The relative  intensity of in- 
dividual V3 gene families was expressed  as the number of cpm 
present in any one of the V3 families divided by the total cpm 
present in the repertoire surveyed. As a control, two normal rhesus 
monkeys were inoculated intravenously with the culture superna- 
tant derived from a virus-free CEMX174 cell line. PBL were ob- 
tained from the animals on day 0, 3, 8, and 15 after inoculation 
and then assessed for TCR-V3 gene family expression. No pertur- 
bation in TCR-V3 repertoire was seen in PBL derived from the 
normal monkeys after virus-free supernatant inoculation when com- 
pared with the V3 expression in their PBL obtained before inocu- 
lation. 
Molecular Cloning and Sequencing of TCR-fl cDNA.  This was 
done using a PCR-based cloning technique, cDNA was derived 
from PBL obtained from monkey 344 on day 14 after infection, 
a time when V37 expansion was seen. It was amplified by PCR 
using a V37 family-specific primer containing an EcoRI restric- 
tion site and a C3 primer containing an XbaI restriction site. In 
an analogous fashion, cDNA derived from monkey L3 PBL ob- 
tained on day 9 after-infection was used in the PCR reaction using 
V~14 family-specific and C3 primers. As a control, cDNA derived 
from the PBL  sampled  before infection from each  of the  two 
monkeys was amplified by PCR to isolate VB7- or V314-bearing 
cDNA. The sequences for the primers were as follows: V37 EcoRI, 
GCG CGA ATT CCT GAA TGC TCC AAG AGC T; V7~14 
EcoRI, GCG CGA ATT CGT CTC TCG AAA AGA GAA GA; 
C~ XbaI, GCG CTC TAG AGT GCT GAC CCC ACT GTG CAC. 
PCR was performed as previously described (20) for 35 cycles. To 
minimize PCR-generated misincorporation,  PFU DNA polymerase 
was used in the PCR reactions.  The PCR products were digested 
with EcoRI and XbaI, and ligated into the plasmid pSP65 (Promega 
Corp., Madison,  WI) for cloning and sequencing. 
Cytotoxicity Assay.  Rhesus monkey B-lymphoblastoid cell lines 
immortalized with Herpesvirus  papio served as target cells (19). The 
B-lymphoblastoid cell lines were infected with recombinant vac- 
cinia  viruses  carrying the SIVm~ gag  or env gene,  and control 
(equine  herpesvirus  gH)  gene  (19). Effector cells  were Ficoll- 
22  TCK in SIV- or SHIV-infected  Macaques diatrizoate-isolated  PBL  or  lymph  node  cells before  and  after 
SIVm~ infection of the monkeys. Lymphocytes were cultured  for 
3 d at  106/ml with Con A (5/zg/ml)  (Sigma Chemical Co.,  St. 
Louis, MO),  washed,  and  then  maintained  for another  3 d  in 
medium supplemented with human recombinant  1I.-2 (20 U/ml) 
(provided by Hoffmann-La Roche, Nutley, NJ). SlCr-labeled target 
cells were incubated  for 5 h with effector cells at E/T cell ratios 
of 100:1, 50:1, 25:1, and 12.5:1. Spontaneous release varied from 
10 to 20%. Specific  release was calculated as [(experimental release 
-  spontaneous release)/(100% release -  spontaneous release)] x 
100. CDS-depleted or CDS-enriched  lymphocytes were prepared 
from the cultured PBL or lymph node cells using monoclonal anti- 
CD4 antibodies or anti-CD8 antibodies and immunomagnetic beads 
(16). These cells were then used in CTL assays  as described above. 
Results 
1-D IEF Characterization of MHC Class I and II Alleles of 
the Monkeys Used in the Studies.  To facilitate interpretation 
of changes in V3 repertoires of SIVm,c-infected rhesus mon- 
keys, we characterized the MHC class I and class II DR mol- 
ecules expressed by the studied animals using  1-D IEF and 
1-D NEPHGE,  respectively (17,  18).  Despite the fact that 
these animals were obtained from several different colonies, 
they displayed extensive sharing of bands defined by the elec- 
trophoretic studies. Four animals (L3, L9, L28, and J28) ex- 
pressed shared bands in the electrophoretic study of MHC 
class II DR-/3 alleles (Fig.  1 A). An electrophoretically defined 
MHC class I band was shared by seven rhesus monkeys (L3, 
L9, L28, J28,  344,  347,  and 290) (Fig.  1 B). Other  MHC 
class I alleles defined by 1-D IEF were also conserved among 
these monkeys (Fig.  1 B). 
Monkeys Acutely Infected with SIVm, Demonstrated an Ex- 
pansion of Specific Vfl-expressing Lymphocyte Subpopulations in 
Both PBL and Lymph Nodes.  We sought to determine whether 
the acute infection of rhesus monkeys with SIVmac would re- 
sult in the expansion of particular V/3-expressing PBL sub- 
populations.  Four monkeys were studied after inoculation with 
molecularly cloned SIVmac 239. TCR VB repertoires of these 
animals were prospectively analyzed using a PCR-based quan- 
titative technique. Expansions of particular V3-expressing T 
cell subpopulations were demonstrated in their PBL after in- 
fection. In monkey 344,  2.1-  and 3.1-fold increases,  respec- 
tively,  in  the  amount  of Vfl7  and  V/314  transcript  were 
documented in PBL obtained 17 d after infection when com- 
pared to the V3 signals  in their preinfection PBL (Fig.  2, A 
and B). Different VB-expressing T  lymphocyte subpopula- 
tions were expanded in PBL of the other three monkeys 14 
and 17 d after SIVm~: 239 infection (Fig.  2, A  and B). VB1- 
and V314-expressing T lymphocytes increased in number 2.6- 
and 2.8-fold,  respectively, in  PBL of monkeys 345;  V/514- 
and V323-expressing T lymphocytes increased in number more 
than  2-fold in  PBL of monkeys 347 and 416. 
To determine  whether  an  SIVmac-Specific stimulation  of 
selected V/3 expressing lymphocytes contributed to the lymph- 
adenopathy seen in the infected monkeys, lymph node lym- 
phocytes were also assessed for TCR V3 repertoire.  As shown 
in Fig. 2 C, the same V3-expressing lymphocyte subpopula- 
tions that expanded in PBL were also increased in the lymph 
node cells of the SIVmac 239-infected moneksy 344 and 345. 
Similar findings were also seen in two monkeys infected 
with another SIVmac isolate,  uncloned SIVmac 251. V/~7- and 
V/516-expressing lymphocytes were increased in number in 
PBL  of the  infected  monkey  247;  an  expansion  of V38- 
expressing lymphocytes was demonstrated after infection in 
PBL of monkey 250  (Fig.  3). 
The Expanded Vfl-extrressing Cell Su~opulations Were CD8 + 
Lymphocytes.  We then  assessed  whether  CD4 + or CD8 + 
lymphocyte populations expressing specific V3 gene families 
were  expanded  after  acute  SIVmac infection.  CD4 +  and 
CD8 + cell subsets in PBL of three acutely infected monkeys 
were positively selected using monoclonal anti-CD4 or anti- 
CD8 antibody-conjugated Dynal beads,  and these purified 
cell populations were assessed for the expression ofTCR V3 
gene families.  Selected V3  gene family-expressing  CD8 § 
but not CD4 +, lymphocyte subpopulations were expanded 
in  PBL sampled  at  multiple  time points  after infection  of 
monkeys 344,  345,  and  290 (Fig.  4). 
Figure  1.  1-D NEPHGE  characterization of  MHC 
class II DR (A) and 1-19  IEF characterization of  MHC 
class I molecules (B) of the rhesus monkeys used in 
the studies. Animal identification numbers are listed 
above the lanes of the gels. DR-tx and -B gene prod- 
ucts are indicated to the right of the gel in A. An 
arrow in B indicates an allele shared by six animals. 
Data from monkey  250 were  not shown  in these gels. 
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Infected Rhesus Monkeys Sharing an Electrophoretically  Defined 
MHC Class I Allele Exhibited an Expansion of Vfll4-expressing 
PBL.  CD8 + lymphocytes recognize viral protein  as pep- 
tide fragments bound to MHC class I molecules. Since the 
selected V3-expressing T lymphocyte subpopulations in the 
SIVmac-infected monkeys were predominantly CD8 +, there 
was reason to predict that particular virus-driven V3-restricted 
responses may be associated with certain MHC class I mole- 
cules. In fact, VB14-expressing T lymphoeytes were expanded 
after infection in PBL of three SIVm~c 239-- or 251-infected 
monkeys (344, 347, and 290) that  expressed the same elec- 
trophoretically defined MHC dass I molecule. Another four 
monkeys in this cohort of experimental animals sharing this 
same electrophoretically defined MHC class I allele  (Fig.  1 
B) were also examined for an expansion of VB14-expressing 
lymphocyte subpopulations in response to such a viral infec- 
tion. These monkeys were inoculated with SHIV and their 
TCR V3 repertoire was assessed prospectively. After the in- 
fection, three of the four monkeys (L3, L9, and L28) exhibited 
a striking expansion of V314-expressing T  lymphocytes in 
their PBL (Fig. 5). The PBL obtained from monkey L3 showed 
an initial increase in VB14-expressing lymphocytes as early 
as day 3 after infection, and 3.3- and 2.3-fold expansions of 
these lymphocyte subpopulations on days 13 and 17, respec- 
tively, after infection.  2.8- and 3.6-fold increases in V314- 
expressing lymphocytes were also seen in PBL obtained from 
the infected monkeys L9 and L28, respectively. In addition, 
the  V37-expressing  T  lymphocyte  subpopulation  was ex- 
panded in PBL of monkey L28. We did not see the expan- 
sion of V314-expressing lymphocytes in PBL of monkey J28 
after infection. This animal was inoculated with the smallest 
quantity of virus (4 TCID50) and, perhaps, did not develop 
as large an initial burst of viremia as the others in this group 
of monkeys. Nevertheless, these results suggest that the SIV- 
mediated expansion of selected V3-expressing  CD8 + lym- 
phocytes may be associated with specific MHC class I mol- 
ecules. 
The SIVmac-driven Expansion  of Selected Vfl-expressing  T 
Lymphocytes Can Be Oligoclonal.  To determine the clonality 
of the selectively expanded VB-expressing lymphocyte sub- 
populations, we examined nucleotide sequences of V-D-J seg- 
ments of TCK eDNA derived from PBL obtained before and 
after infection from monkeys L3 and 344. Polyclonal sequences 
were found in the V314 eDNA clones generated by PCK 
from the preinfection PBL of monkey L3 (Fig. 6 A). In con- 
trast, the eDNA clones derived from this monkey's PBL sam- 
pled on day 9 after infection, a time when V314 expansion 
was detected by PCR quantitation,  were oligoclonal.  Four 
predominant  clones were seen in  the  50 V314-dones  se- 
quenced, representing 50, 20, 16, and 10% of the clones (Fig. 
6 B). Similar results were also seen in the V37 eDNA clones 
derived from monkey 344 PBL obtained before and after in- 
fection (Fig. 7, A and B). 14 of 30 characterized clones (47%) 
had an identical junctional sequence which was rearranged 
with the J3 2.7 gene segment. The other predominant clone, 
D14-03, represented 20%  of the total characterized clones. 
Figure 2.  PCR analysis of TCR V~ expression in PBL or lymph nodes obtained from SIVm~c 239-infected rhesus monkeys. (A) Autoradiogram 
ofTCK V~ transcripts in PBL derived from monkey  344 on day 0 (upper  panel) and day 17 (lower  panel) after infection. (B) Comparison of VB expression 
in postinfection PBL with that in preinfection PBL. Individual VB expression was expressed as the percentage of total VB cpm in PBL observed at 
each time point as previously  described (11, 16). A >1.5-fold increase in the ratio was considered significant (16). (C) Comparison of the V~ expression 
in lymph node lymphoeytes of two monkeys obtained before and after infection. Shown are individual V~/expressions in lymphocytes from lymph 
nodes obtained preinfection and on day 20 postinfection. 
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Figure 4.  V~ family expression in CD4+  (A) or CD8+  (B) lymphocytes of rhesus monkeys before and after infection with SIVmac 239 or SIVm 
251. CD4+  or CD8+  lymphocytes were purified using anti-CD4 or anti-CD8 antibody-conjugated  magnetic beads. 
26  TCR in SIV- or SHIV-infected Macaques These results  suggest  that  the expansion  of selected VB- 
expressing T lymphocyte subpopulations soon after infection 
with SIVmac or SHIV is oligoclonal. 
The Expansion of Selected Vfl-expressing Lymphocytes Coin- 
cided with the Emergence of SIVm~c-specific CD8 + CTL.  We 
sought to determine whether the expansion of these selected 
V3-expressing  CD8 + lymphocyte subpopulations  is  tem- 
porally associated with the emergence of functional SIVmac- 
specific CTL. For this purpose, PBL or lymph node cells ob- 
tained from two acutely infected monkeys were assessed for 
SIVma:Specific CTL responses. At the time the V~14-ex- 
pressing CD8 + lymphocyte subpopulation was expanded in 
PBL of monkey 290 on day 18 and 20 after SIVmac  infection, 
SIVmac Gag-  and  Env-specific CTL  were readily  demon- 
strated in PBL obtained at these same time points (Fig. 4, 
Tables 1 and 2). Similarly, SIVm~:specific  CTL were also de- 
tected in lymph node cells obtained  from monkey 344 on 
day 20 after-infection,  the time when the V314- and VB7- 
expressing lymphocyte subpopulation  expansions were seen 
(Fig. 2 C, Tables 1 and 2). These virus-specific CTL were 
CD8 +, but not CD4 + cells, since depletion of CD8 § cells 
in PBL resulted in the abrogation  of specific CTL activity 
(data not shown).  Furthermore, SIVmac Gag-specific CTL 
from the monkeys 344  and 290 consistently  lysed SIVm~c 
Gag-expressing autologous targets and targets expressing this 
shared electrophoretically defined MHC class I allele, but not 
fully MHC class I mismatched allogeneic targets. Therefore, 
there appeared to be a correlation between the expression of 
this electrophoretically  defined MHC class I allele, the ex- 
pansion of a V314-expressing CD8 + lymphocyte subpopu- 
lation,  and the emergence of SIVmac Gag-specific CTL re- 
sponse. 
The Expansion of Selected Vfl-expressing Lymphocytes Coin- 
cided with the Emergence  and Clearance  of  SIV Antigen in Plasma. 
Finally, we sought to determine whether there is a correla- 
tion between viral burden and the expansion of selected VB- 
expressing lymphocytes in rhesus monkeys after infection with 
SIVm~c. Plasmas were sequentially obtained from the infected 
monkeys and assessed for SIV p27 antigen.  The expansion 
of selected V3-expressing lymphocytes appeared to coincide 
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CLONE  Vg  D+N  J~  FREQUENCY 
CDR3 
D0-16  CASS  GTRD  YDYTFG  Jgl.2  1/20 
D0-10  ....  ITGGSN  ......  Jgl.2  1/20 
D0-04  ---  RWVEN  ......  J~l.2  1/20 
D0-22  ....  LSGGAS  ......  J~l.2  1/20 
D0-23  ....  PRQIN  ......  J~l.2  1/20 
D0-30  ....  LAVSEP  ......  JSl.2  1120 
D0-05  ....  REPG  ......  JSl.2  1/20 
D0-17  ....  KQGEDD  EKLF--  J~l.4  1/20 
D0-18  ....  FQGSD  EKLF--  JSl.4  1/20 
D0-26  ---  GRRVW  EKLF--  JEI.4  1/20 
D0-33  ---  RTGTGANRG  EKLF--  JSl.4  1/20 
D0-12  ....  LEGQGD  NQPQY--  JSl.5  1/20 
D0-14  ---  QGT  NQPQY--  JEI.5  1/20 
D0-31  ....  LLSGGG  NQPQY--  JSl.5  1/20 
D0-24  ....  SRPGA  'AQLF--  J~2.2  1/20 
D0-06  ....  RSADA  TDPQY--  JS2.3  1/20 
D0-15  ....  YRDS  TDPQY--  J~2.3  1/20 
D0-25  ....  LSRDS  TDPQY--  JS2.3  1/20 
D0-03  ....  YGRRKAD  NTQY--  J~2.4  1/20 
D0-01  ....  IGAAE  NTQY--  JS2.4  1/20 
CLONE  Vg  D+N  Jg  FREQUENCY 
i--  CDR3 
D0-22  CASS  LTGVG  YDYTFG  Jgl.2  1/16 
D0-15  ....  QAIG  EKLF--  Jgl.4  1/16 
D0-04  ....  GQRGPN  EKLF--  Jgl.4  1/16 
D0-13  ....  QGRTS  NQPQY--  Jgl.5  1/16 
D0-11  ---  RRAQGD  EQPQY--  Jgl.5  1/16 
D0-09  ....  EHL  DQPQY--  J~l.5  1/16 
D0-01  ....  RRAD  NSPLN--  Jgl.6  1/16 
D0-06  ....  TGQAG  NSPLH--  Jgl.6  1/16 
D0-02  ....  QGLGGAD  NEQF--  J~2.1  1/16 
D0-14  ....  QEGSPSSS NEQF--  J~2.1  1/16 
D0-10  ....  AYG  NEQF--  Jg2.1  1/16 
D0-07  ....  EQGTL  TDPQY--  Jg2.3  1/16 
D0-04  ....  QDADS  TDPQY--  Jg2.3  1/16 
D0-03  ....  HPGLG  PNTQY--  J~2.4  1/16 
D0-05  ....  QDGGQGG DNTQY--  Jg2.4  1/16 
D0-12  ....  LSQV  INTQY--  J~2.4  1/16 
B 
CLONE  Vr  D+N  Jg  FREQUENCY 
,  CDR3 
D9-09  CASS  LDRG  WDYTFG  Jgl.2  8/50 
D9-05  ....  TRDIN  EKLF--  J~1.4  10/50 
D9-15  .....  GDRN  TEAF--  J81.1  5/50 
D9-16  .....  RDRN  NQPQY--  Jgl.5  1/50 
D9-03  ....  FYGGAR  GQPQY--  J~l.5  25/50 
D9-02  .....  EGQSDT  AQLF--  Jg2.2  1/50 
Figure  6.  Amino acid sequences in the TCK-fl junctional region of 
V~14 recombinant clones derived from PBL collected from monkey 1.03 
before (A) and on day 9 (/3) after infection. The frequency of each recom- 
binant in the total cDNA clones characterized is indicated.  V, variable; 
N, nontemplated; D, diversity; J, joining; CDR3, complementary deter- 
mining region  (21,  22). 
CLONE  Vg  D§  J8  FREQUENCY 
,  CDR3  --I 
D14-02  CASS  QDPGGR  GEQYFG  J~2.7  14/30 
D14-20  ......  T--VL  ......  Jg2.7  2/30 
D14-04  ......  NR-L  NQP  ....  J81.5  6/30 
D14-10  ......  R-S  NQP  ....  J~l.5  4/30 
D14-07  ......  RVS  NQP  ....  Jgl.5  3/30 
D14-08  .....  EKVS  NQP  ....  Jgl.5  1/30 
Figure  7.  Amino acid sequences in the TCR-fl junctional region of 
V~7 recombinant clones derived from PBL obtained from monkey 344 
before (A) and on day 14 (B) after infection. The frequency of each recom- 
binant in the total cDNA clones  characterized is indicated. 
Table  1.  Lymphoqtes of Acutely SIVa-infected Rhesus 
Monkeys Lysed SIV~ Gag- and Env-expressing Autologous 
Target Cells at the Time of Peak Expansion of Vff T Cell 
Subpopulations 
with the emergence and clearance of SIV viral protein from 
the plasma  of the infected monkeys (Fig.  8).  Plasma  an- 
tigenemia was maximal in monkeys 344, 345, 347, and 416 
on  day  14  after infection;  an  expansion of selected  V~-  Mm290 
expressing  T cells in PBL was detected  in these animals on 
day 14 and was maximal on day 17 after infection (Fig.  8 
A). A similar correlation between antigenemia and V3 sub- 
population expansion was also seen in the other two rhesus 
monkeys  studied  (290,  247)  after  acute  infection  with  Mm344 
SIVm~c251 (Fig.  8 B). 
Discussion 
The present study indicates that acute infection of rhesus 
monkeys with SIVmac and SHIV resulted in an oligoclonal 
expansion of selected V~-expressing CD8 + T lymphocytes. 
These findings are consistent with the recent demonstration 
that PBL of humans acutely infected with HIV-1 exhibited 
an oligoclonal expansion of selected  V3-expressing CD8 + 
T cells with HIV-l-specific cytotoxic function (10). Our study 
extends those findings in HIV-l-infected humans by demon- 
strating that lymphocytes expressing selected V/~ families were 
Percent lysis with* 
Effectors*  E:T  Katio  Cont  Gag  Env 
100:1  2  37  17 
50:1  0  30  13 
25:1  0  18  0 
12.5:1  0  6  0 
100:1  2  27  16 
50:1  2  16  12 
25:1  0  7  9 
12.5:1  1  5  3 
* Effector cells from the monkey 290 were PBL sampled on day 18 after 
SIVmac infection; those from the monkey 344 were lymph node lympho- 
cytes obtained on day 20 after viral infection. Lymphocytes  were cul- 
tured for 3  d  with Con A,  and then maintained for  another 3  d in 
IL-2-containing medium before CTL assay. 
Target cells were autologous B-lymphoblastoid cell lines infected with 
recombinant vaccinia viruses carrying the SIVm~ gag, env, and equine 
herpesvirus gH (Cont) genes.  Target  cells were labeled with slCr and 
incubated for 5  h with effector cells at the indicated E/T ratios. 
28  TCR in SIV- or SHIV-infected Macaques Table  2.  SIVma~  Gag-specific Lysis by CD8-enriched Lymphocytes from SIVa-infected  Monkeys Appeared to Be Associated 
with the Expression of an Electrophoretically Defined MHC Class I Allele 
Percent lysis of target cells from* 
Effectors*  E:T Ratio  Mm290  Mm347  Mm344  Mm416 
Mm290 
Mm344 
Cont  Gag  Cont  Gag  Cont  Gag  Cont  Gag 
100:1  12  53  0  24  ndS  nd  5  7 
50:1  11  46  3  22  nd  nd  9  5 
25:1  8  39  4  21  nd  nd  9  5 
12.5:1  3  28  1  7  nd  nd  12  7 
100:1  nd  nd  8  29  7  38  8  5 
50:1  nd  nd  3  19  3  26  2  3 
25:1  nd  nd  1  8  1  9  4  4 
12.5:1  nd  nd  0  6  0  8  2  5 
* CDS-enriched effector cells of monkey 290 were derived from PBL sampled on day 20 after infection; those of monkey 344 were from lymph 
node lymphocytes obtained on day 20 after infection. 
Target cells were prepared from Herpesvirus papio-transformed B-lymphoblastoid cell lines derived from the animals indicated. 1-D IEF showed 
that cell lines from the monkeys 344, 347, and 290, but not the monkey 416, expressed a shared MHC class I band. 
S nd, not done. 
expanded not only in PBL, but also in lymphoid tissues of 
infected monkeys. The present findings also suggest that the 
virus-driven expansion of selected V/3-expressing  lymphocytes 
may be associated with  specific  electrophoretically defined 
MHC class I molecules. Furthermore, these studies show that 
the expansion of the selected V3-expressing lymphocytes coin- 
cided with the appearance of SIVmac-specific CTL responses 
as well as the emergence and clearance of SIV antigen in plasma 
after infection. Thus, these studies may implicate the expanded 
subpopulations  of CD8 + T  cells  in  the immune  response 
that  contains  early AIDS virus spread. 
The SIVmac-mediated expansion of selected V3-expressing 
lymphocytes in PBL of the monkeys was less dramatic than 
the V/3-expressing  lymphocyte subpopulation expansions  seen 
in HIV-l-infected humans.  This may simply reflect differ- 
ences in the virologic events observed in HIV-1 and SIVmac 
infections. The period of early,  high level viral antigenemia 
appears to last longer in primary HIV-1 infection of humans 
than in acute SIVm,c infection of rhesus monkeys (1-5). This 
more persistent antigenemia  may drive a greater clonal ex- 
pansion  of CD8 + T  cells. 
We have recently shown that  SIV~mmPBj14 mediates the 
expansion of pig-tailed macaque T  lymphocytes expressing 
TCR V37 and V314 gene families in vitro and in vivo (11). 
It is interesting that we have observed not only an expansion 
of  selected  VB-expressing  lymphocyte  subpopulations  in 
both the SIVsmmPBj14-infected  pig-tailed macaques and the 
SIVm~- and SHIV-infected rhesus monkeys, but that expres- 
sion of V~14-expressing T cell subpopulations occurred pref- 
erentially in both settings. An explanation for this particular 
preferential  VB expansion is not readily apparent.  This finding 
is not likely to represent  an artifact in the PCR-based V3 
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repertoire analyses,  since we did not observe such a skewing 
in  VB  expression  in  PBL  obtained  from  control  animals 
inoculated  with  virus-free  supernatant  from  the  cell  line 
CEMX174 (see Materials and Methods). Moreover, we saw 
oligoclonal V/314 sequences in cDNA derived from the PBL 
of monkeys which exhibited this increase in V~/14 expres- 
sion, but not from the PBL of a monkey which displayed 
only V~23  expansion  (data not  shown). 
The  expansion  of a particular  CD8 +  Vfl-expressing  T 
lymphocyte subpopulation might be expected if the monkeys 
shared an MHC class I allele and were responding to the same 
epitope of the  infecting  virus.  However, lymphocytes ex- 
pressing  the  same V/3-gene families can also be driven by 
different MHC class I-viral peptide complexes (10,  23). In 
fact,  Vf114-expressing  T  lymphocytes  were  expanded  in 
CD8 + PBL obtained after infection from monkey 345,  an 
animal that did not appear to express the electrophoretically 
defined MHC class I allele shared by the other seven monkeys. 
Such a selectivity in V~/responsiveness may explain why two 
different macaque species, each infected with a different SIV 
isolate, might demonstrate expansions of similar T lympho- 
cyte subpopulations. 
SIVsmmPBj14, unlike  SIVmac or SHIV,  stimulates  the  in 
vitro proliferation and expansion of both CD4 + and CD8 § 
lymphocyte subpopulations, and induces an acute lethal dis- 
ease in pig-tailed macaques.  The ability of SIVsmmPBj14 to 
stimulate proliferation and activation of resting PBL in vitro 
is predictive of its acute lethal pathogenicity in vivo (24). 
These properties of SIVsmmPBj14 appear to be unique among 
primate immunodeficiency viruses.  While we cannot exclude 
the possibility that the SIVsmmPBj14-induced  immunologic 
events in infected pig-tailed macaques may simply reflect an A 
15 
IO 
r 
U  0 
~"  i0 o 
;> 
B 
20 
~  15" 
0 
r  5" 
;> 
I 
---[3--  vp7  A  Mm344 
￿9  "--0~  vp,4  ~  ~  ~7~ 
.0.S 
li 25 
O 
Days  post  infection 
Mm347 
.0. 
oo.O~  "., 
.. 
: .....  ,'o  20 
Days  post  infection 
0 75 
N 
II 
~  ~"  ~  Vl~l  Mm345 
~"  W  I0- 
0  ~  ~  i 
IU  .o 
Days  post  infection 
~ [  Mm416 
~  vp2~ 
~,o 
~  ~  . 
o  Ill  +~P() 
Days  post  infection 
I 
073 
0~; 
1125 
0 
I 
0 7~ 
0.+ 
0.25 
O 
g~ 
E 
g~ 
n  o 
Mm290 
Vl~,14 
~  t 
~  %'~ 
7  "￿9 
o  ~  1o  1~  2'o  25  ,,, 
Days  post  infection 
15  20 
0  0 
~  10- 
o  S  ~.~  ;> 
0  0  v 
Mm247 
Vl~7  A 
+  +,6 
s  ".. 
,;  "',.% 
,  I('  '15  210  2, 
Days  post  infection 
2 
E 
Js  '~ 
I  x 
115 
t/3 
I) 
Figure  8.  Correlation between SIV antigenemia and the expansion of selected VB-expressing lymphocyte subpopulations in SIVmac 239- (A) and 
SIVmac 251-  (B) infected monkeys. Indicated are SIV p27 protein concentrations in plasma and the expansion of selected V3 gene families. 
exaggeration of the SIVmac- or SHIV-mediated expansion of 
selected VB-expressing T lymphocytes of the infected rhesus 
monkeys, these events may be driven by a superantigen-like 
property  of this unusual virus. 
The oligoclonality of the expanded VB-expressing cells in 
PBL of the SIVmac -infected  monkeys  is likely  to reflect a 
virus-specific T lymphocyte  response. It is of interest to de- 
termine the viral antigen(s)  that are eliciting  this immune 
response. At least some of the antigen(s) stimulating the ex- 
pansion of V3-expressing lymphocytes  may be encoded by 
viral  gene(s)  other  than  the  envelope-coding  region  of 
SIV  ....  This possibility  is supported by the demonstration 
that both SIVm~c- and SHIV-infected rhesus monkeys sharing 
a single MHC class I allele exhibited the same expansion of 
V314-expressing T lymphocyte subpopulations in their PBL 
(Figs.  2 and 5). 
The present study indicates a correlation between the ex- 
pansion of selected V3-expressing  CD8 + lymphocyte  sub- 
populations, the emergence of AIDS virus-specific CTL re- 
sponses, and the appearance and clearance of SIV antigen in 
plasma of the monkeys. Elucidating the molecular aspects of 
the interactions of the selected V3-expressing  T cells with 
SIVmac will further define the role played by these lympho- 
cyte subpopulations  in containing  an SIVr,  ac infection. 
30  TCR in SIV- or SHIV-infected Macaques The authors thank Michael Wyand and Kelledy Mason of TSI Mason Laboratory for providing the blood 
samples from SHIV-infected monkeys, and  Emilie McBride and  Shelley Kotlikoff for preparing  this 
manuscript. 
This work was supported by National Institutes of Health grants AI01189, AI36628, AI33832, AI20729, 
and CA50139. 
Address correspondence to Zheng Wei Chen, Harvard Medical School, Beth Israel Hospital, 330 Brook- 
line Avenue, Boston, MA 02215. 
Received for Fublication  4  November  1994  and in  revised form  15 March  1995, 
References 
1.  Daar, E.S., T. Moudgil, lL.D. Meyer, and D.D. Ho. 1991. Tran- 
sient high levels of viremia in patients with primary human 
immunodeficiency virus  type 1 infection.  N.  Engl. J.  Med. 
324:961-964. 
2.  Clark, S.J., M.S. Saag, W.D. Decker, S. Campbell-Hill, J.L. 
Robertson, P.J. Veldkamp,  J.C. Kappes, B.H. Hahn, and G.M. 
Shaw. 1991. High titers of cytopathic virus in plasma of pa- 
tients with symptomatic primary HIV-1 infection. N. Engl. 
j. Med. 324:954-960. 
3.  Piatak, M.J.,  M.S. Saag, L.C. Yang, S.J. Clark, J.C.  Kappes, 
K.-C. Luk, B.H. Hahn, G.M. Shaw, and J.D.  Lison. 1993. 
High levels of HIV-1 in plasma during all stages of infection 
determined by competitive  PCR. Science (Wash. DC).  259: 
1749-1754. 
4.  Graziosi, C., G. Panteleo, L. Butini, J.E Demarest, M.S. Saag, 
G.M. Shaw, and A. Fauci. 1993. Kinetics of human immuno- 
deficiency  virus type 1 DNA and RNA synthesis during pri- 
mary HIV-1 infection. Proa Natl. A_cad. Sci. USA. 90:6405-6409. 
5.  Reimann, K.A., K. Tenner-Racz, P. Racz, D. Montefiori, Y. 
Yasutomi, W. Lin, B. Ransil, and N.L. Letvin. 1994.J. Virol. 
68:2363-2370. 
6.  Safrit, J.T., A.Y. Lee, C.A. Andrews, and R.A. Koup. 1994. 
A region of third variable loop of HIV-1 gp120 is recognized 
by HLA-B7-restricted CTLs from two acute seroconversion 
patients. J. Immunol.  153:3822-3830. 
7.  Safrit, J.T., C.A. Andrews, T. Zhu, D.D. Ho, and R.A. Koup. 
1994. Characterization of  human immunodeficiency  virus type 
1-specific  cytotoxic T lymphocyte clones isolated during acute 
seroconversion: recognition  of autologous  virus  sequences 
within a conserved immunodominant  epitope. J. Ex  F. Med. 
179:463-472. 
8.  Koup,  R.A., J.T. Safrit, Y. Cao,  C.A.  Andres, Y. Wu,  G. 
McLeod, W. Borkowsky, C. Farthing,  and D.D.  Ho. 1994. 
Temporal association of  cellular immune response with the ini- 
tial control of viremia in primary HIV-1 syndrome. J.  Virol. 
68:4650-4655. 
9.  Yasutomi,  Y., K.A. Reimann, C.I. Lord, M.D. Miller, and N.L. 
Letvin. 1993. Simian immunodeficiency virus-specific  CD8 + 
lymphocyte response  in acutely  infected  rhesus monkeys.J. Virol. 
67:1707-1711. 
10.  Pantaleo,  G., J.F. Demarest, H. Soudeyns,  C. Graziosi, E Denis, 
J.W. Adeisberger,  P. Borrow, M.S. Saag, G.M. Shaw, R. Sekaly, 
and A.S. Fauci. 1994. Major expansion ofCD8+ T cells with 
a predominant Vfl usage during the primary immune response 
to HIV. Nature (Lond.). 370:463-467. 
11.  Chen,  Z.W., Z.  Kou, L.  Shen, J.D.  Regan,  C.I. Lord, M. 
Halloran, D. Lee-Parritz, P.N. Fultz, and N.L. Letvin. 1994. 
An acutely lethal simian immunodeficiency virus stimulates 
expansion  of Vfl7-  and  Vf114-expressing T  lymphocytes. 
Proc. Natl.  Acad. Sci. USA.  91:7501-7505. 
12.  Desrosiers, R.C. 1990. The simian immunodeficiency viruses. 
Annu. Rev. Immunol.  8:557-578. 
13.  Letvin, N.L. 1990. Animal models for AIDS. Immunol. Today. 
11:322-326. 
14.  Letvin, N.L., and N.W. King. 1990. Immunologic and patho- 
logic manifestations of the infection of rhesus monkeys with 
simian immunodeficiency virus of macaques. J. Acquired Im- 
mune Defic. Syndr. 3:1023. 
15.  Li, J., C.I. Lord, W. Haseltine, N.L. Letvin, andJ. Sodroski. 
1992. Infection of  cynomolgus monkeys  with a chimeric HIV-1/ 
SIVmac virus that expresses the HIV-1 envelope glycoprotein. 
J. Acquired Immune  Defic. Syndr. 1992:5:639-646. 
16.  Chen, Z.W., Z. Kou, L. Shen, K.A. Reimann, and N.L. Letvin. 
1993. Conserved T cell receptor repertoire in simian immuno- 
deficiency virus-infected rhesus  monkeys. J.  Immunol.  151: 
2177-2187. 
Chen, Z.W., A.L. Hughes, A. Dogon, N.L. Letvin, and D.I. 
Watkins. 1992. Molecular cloning of orangutan  and gibbon 
MHC class I molecules: the HLA-A and -B loci diverged over 
30 million years ago. J. Immunol.  148:2547-2554. 
18.  Lekutis, C., and N.L. Letvin. 1995. Biochemical and molec- 
ular characterization of rhesus monkey major histocompati- 
bility complex class II DR. Hum. Immunol.  43:74-82. 
19.  Chen, Z.W., L. Shen, M.D. Miller, S.H. Ghim, A.L. Hughes, 
and N.L. Letvin. 1992. Cytotoxic T lymphocytes do not ap- 
pear to select for mutations in an immunodominant  epitope 
of simian immunodeficiency virus gag.J. Immunol. 149:4060- 
4066. 
20.  Chen, Z.W., H. Yamamoto, D.I. Watkins, G. Levinson, and 
N.L. Letvin.  1992. A predominant  use of a T  cell receptor 
Vfl gene family in SIV gag-specific cytotoxic T lymphocytes 
in a rhesus monkey. J.  Virol. 66:3913-3917. 
21.  Hingorani, R., I. Choi, P. Akolkar, B. Gulwani-Akolakar, R. 
Pergolizzi, J. Silver, and P.K. Gregerson.  1993. Clonal pre- 
dominance oft cell receptors within the CD8+ CD45 RO+ 
subset in normal human subjects.J. Immunol. 151:5762-5769. 
22.  Cand6ias, S., C. Waltzinger, C. Benoist, and D. Mathis. 1991. 
The Vf117  +  T cell repertoire: skewed Jfl usage after thymic 
selection; dissimilar CDR3s in CD4 + versus CD8 + cells.  J. 
Ex  F. Med. 174:989-1000. 
23.  Smith,  T.J., N. Terada, C.C.  Robinson,  and E.W. Gelfand. 
1993. Acute infectious mononucleosis stimulates the selective 
expression/expansion of Vfl6.1-3 and Vfl7 T cells. Blood. 81: 
1521-1526. 
24.  Novembre, F.J., P.R. Johnson,  M.G. Lewis, D.C. Anderson, 
S. Klumpp, H.M. McClure, and V.M. Hirsh.  1993. Multiple 
viral determinants contribute to pathogenicity of the acutely 
lethal SIVsmmPBj14.  J.  Virol. 67:2442-2447. 
17. 
31  Chen et al. 